Trademarkia Logo

Canada

C$
GONDOLABIO
FORMALIZED

on 5 Mar 2025

Last Applicant/ Owned by

Bridgebio Pharma, Inc.

3160 Porter Dr., Suite 250 Palo Alto CA 94304

US

Serial Number

2384380 filed on 6th Feb 2025

GONDOLABIO

Trademark usage description

pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and d Read More

Classification Information


Class [005]
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders.


Classification kind code

12

Class [042]
Pharmaceutical research and development services.


Classification kind code

12

Mark Details


Serial Number

2384380

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 6th Mar 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 5th Mar 2025
Created
Submitted for opposition 31
on 5th Mar 2025
Formalized
Submitted for opposition 228
on 6th Feb 2025
International Registration
Submitted for opposition 30
on 6th Feb 2025
Filed